Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation. 2022

Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.

Long QT syndrome (LQT) is an inherited primary arrhythmic disorder characterized by prolonged QT interval on the surface electrocardiogram and life-threatening arrhythmia. In this study, a skin biopsy was obtained from an LQT type 2 (LQT2) patient, who carried a nonsense mutation (c.1956C > A; p.Y652X) in the potassium voltage-gated channel subfamily H member 2 (KCNH2) gene. The skin fibroblasts were reprogrammed by non-integrated Sendai viral method to generate a patient-specific induced pluripotent stem cell (iPSC) line. The generated iPSC line showed typical embryonic stem cell-like morphology, exhibited normal karyotype, expressed pluripotency markers, and was capable to differentiate into three germ layers.

UI MeSH Term Description Entries
D008133 Long QT Syndrome A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME. Electrocardiogram QT Prolonged
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072237 ERG1 Potassium Channel One of three members of the ether-a-go-go (EAG) POTASSIUM CHANNELS gene family comprising ether-a-go-go (eag), eag-like (elk) and eag-related (erg) subfamilies. Ether-a-go-go-related gene 1 (ERG1) also known as KCNH2, encodes the pore-forming subunit of a rapidly activating-delayed rectifier potassium channel that plays an essential role in the final repolarization of ventricular action potential. Loss-of-function mutations in human hERG1 is associated with life-threatening ARRHYTHMIA. Ether-A-Go-Go-Related Potassium Channel 1,Kv11.1 Protein-Potassium Channel,Potassium Voltage-Gated Channel, Subfamily H, Member 2,Channel, ERG1 Potassium,Channel, Kv11.1 Protein-Potassium,Ether A Go Go Related Potassium Channel 1,Kv11.1 Protein Potassium Channel,Potassium Channel, ERG1,Protein-Potassium Channel, Kv11.1
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D057026 Induced Pluripotent Stem Cells Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS. Human Induced Pluripotent Stem Cell,IPS Cell,IPS Cells,Induced Pluripotent Stem Cell,Fibroblast-Derived IPS Cells,Fibroblast-Derived Induced Pluripotent Stem Cells,Human Induced Pluripotent Stem Cells,hiPSC,Cell, Fibroblast-Derived IPS,Cell, IPS,Cells, Fibroblast-Derived IPS,Cells, IPS,Fibroblast Derived IPS Cells,Fibroblast Derived Induced Pluripotent Stem Cells,Fibroblast-Derived IPS Cell,IPS Cell, Fibroblast-Derived,IPS Cells, Fibroblast-Derived

Related Publications

Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
March 2024, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
July 2022, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
December 2021, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
October 2020, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
March 2016, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
August 2021, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
February 2023, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
July 2021, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
August 2021, Stem cell research,
Fengfeng Guo, and Yaxun Sun, and Hongkun Wang, and Hao Wang, and Jingjun Zhou, and Hangping Fan, and Jun Su, and Tingyu Gong, and Chenyang Jiang, and Ping Liang
April 2022, Stem cell research,
Copied contents to your clipboard!